|
| 37385974 | Stricker Learning Span criterion validity: a remote self-administered multi-device compatible digital word list memory measure shows similar ability to differentiate amyloid and tau PET-defined biomarker groups as in-person Auditory Verbal Learning Test. | J Int Neuropsychol Soc | 2024 |
| 37963289 | Modeling the temporal evolution of plasma p-tau in relation to amyloid beta and tau PET. | Alzheimers Dement | 2024 |
| 37804318 | Synthesizing images of tau pathology from cross-modal neuroimaging using deep learning. | Brain | 2024 |
| 38014536 | Mayo normative studies: regression-based normative data for ages 30-91 years with a focus on the Boston Naming Test, Trail Making Test and Category Fluency. | J Int Neuropsychol Soc | 2024 |
| 37831661 | Uncovering the distinct macro-scale anatomy of dysexecutive and behavioural degenerative diseases. | Brain | 2024 |
| 37932910 | Vascular risk, gait, behavioral, and plasma indicators of VCID. | Alzheimers Dement | 2024 |
| 38091751 | Neurite-based white matter alterations in MAPT mutation carriers: A multi-shell diffusion MRI study in the ALLFTD consortium. | Neurobiol Aging | 2024 |
| 36216947 | Author Correction: Performance of plasma phosphorylated tau 181 and 217 in the community. | Nat Med | 2023 |
| 38025797 | Association of Cerebrovascular Imaging Biomarkers, Depression, and Anxiety, with Mild Cognitive Impairment. | J Alzheimers Dis Rep | 2023 |
| 37485642 | Longitudinal rates of atrophy and tau accumulation differ between the visual and language variants of atypical Alzheimer's disease. | Alzheimers Dement | 2023 |
| 37703605 | Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer's disease research. | Neuroimage Clin | 2023 |
| 37586881 | Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging. | Neurology | 2023 |
| 37886506 | Advancing Tau-PET quantification in Alzheimer's disease with machine learning: introducing THETA, a novel tau summary measure. | Res Sq | 2023 |
| 37580163 | Association of Plasma Biomarkers of Alzheimer Disease With Cognition and Medical Comorbidities in a Biracial Cohort. | Neurology | 2023 |
| 37986913 | Boston criteria v2.0 for cerebral amyloid angiopathy without hemorrhage: An MRI-neuropathological validation study. | medRxiv | 2023 |
| 38045300 | A limbic-predominant amnestic neurodegenerative syndrome associated with TDP-43 pathology. | medRxiv | 2023 |
| 37567353 | Physicians' perspectives on percutaneous left atrial appendage occlusion for patients with atrial fibrillation. | Am Heart J | 2023 |
| 37638398 | Cerebral Microbleed Patterns and Cortical Amyloid-β: The ARIC-PET Study. | Stroke | 2023 |
| 36959061 | Antiphospholipid syndrome mimicking posterior cortical atrophy and the "railroad track" sign on brain fluorodeoxyglucose-positron emission tomography. | J Neurol Sci | 2023 |
| 37118867 | Field strength difference in extent of artifacts induced by CERTAS Plus valves in patients with idiopathic normal pressure hydrocephalus. | Neuroradiol J | 2023 |
| 37248223 | Evidence against a temporal association between cerebrovascular disease and Alzheimer's disease imaging biomarkers. | Nat Commun | 2023 |
| 37279785 | Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis. | Brain | 2023 |
| 37013176 | Default mode network failure and neurodegeneration across aging and amnestic and dysexecutive Alzheimer's disease. | Brain Commun | 2023 |
| 37304065 | Impact of Atrial Fibrillation on Outcomes in Patients Hospitalized With Nontraumatic Intracerebral Hemorrhage. | Mayo Clin Proc Innov Qual Outcomes | 2023 |
| 37004136 | Objective assessment of patients with idiopathic normal pressure hydrocephalus following ventriculoperitoneal shunt placement using activity-monitoring data: pilot study. | Neurosurg Focus | 2023 |
| 37434879 | Altered within- and between-network functional connectivity in atypical Alzheimer's disease. | Brain Commun | 2023 |
| 37302032 | Diffusivity Changes in Posterior Cortical Atrophy and Logopenic Progressive Aphasia: A Longitudinal Diffusion Tensor Imaging Study. | J Alzheimers Dis | 2023 |
| 37269398 | Plasma biomarkers for prediction of Alzheimer's disease neuropathologic change. | Acta Neuropathol | 2023 |
| 37202168 | β-Amyloid Load on PET Along the Continuum of Dementia With Lewy Bodies. | Neurology | 2023 |
| 37168417 | Contemporary trends and barriers to oral anticoagulation therapy in Non-valvular atrial fibrillation during DOAC predominant era. | Int J Cardiol Heart Vasc | 2023 |
| 37268436 | Clinicoradiologic and Neuropathologic Evaluation of Corticobasal Syndrome. | Neurology | 2023 |
| 37068958 | White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer Disease. | Neurology | 2023 |
| 37164654 | Association of Polysomnographic Sleep Parameters With Neuroimaging Biomarkers of Cerebrovascular Disease in Older Adults With Sleep Apnea. | Neurology | 2023 |
| 36999481 | APOE ε4 influences within and between network functional connectivity in posterior cortical atrophy and logopenic progressive aphasia. | Alzheimers Dement | 2023 |
| 36820004 | Diagnosis and Management of Posterior Cortical Atrophy. | Curr Treat Options Neurol | 2023 |
| 36789483 | Predicting amyloid PET and tau PET stages with plasma biomarkers. | Brain | 2023 |
| 36591730 | Multisite ALLFTD study modeling progressive empathy loss from the earliest stages of behavioral variant frontotemporal dementia. | Alzheimers Dement | 2023 |
| 36721911 | Deciphering the clinico-radiological heterogeneity of dysexecutive Alzheimer's disease. | Cereb Cortex | 2023 |
| 36443011 | Cross-sectional Associations of β-Amyloid, Tau, and Cerebrovascular Biomarkers With Neurodegeneration in Probable Dementia With Lewy Bodies. | Neurology | 2023 |
| 36806507 | Associations of Neurodegeneration Biomarkers in Cerebrospinal Fluid with Markers of Alzheimer's Disease and Vascular Pathology. | J Alzheimers Dis | 2023 |
| 36737114 | Population-Based Evaluation of Total Protein in Cerebrospinal Fluid. | Mayo Clin Proc | 2023 |
| 36731814 | Cross-scanner harmonization methods for structural MRI may need further work: A comparison study. | Neuroimage | 2023 |
| 35894392 | Change in Morphological Features of Enlarged Subarachnoid Spaces Following Treatment in Idiopathic Normal Pressure Hydrocephalus. | J Magn Reson Imaging | 2023 |
| 36256511 | The many faces of globular glial tauopathy: A clinical and imaging study. | Eur J Neurol | 2023 |
| 34310832 | Comparison of CSF phosphorylated tau 181 and 217 for cognitive decline. | Alzheimers Dement | 2022 |
| 35412102 | Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer's disease. | Acta Neuropathol | 2022 |
| 35841897 | Cerebral amyloid angiopathy criteria: the next generation. | Lancet Neurol | 2022 |
| 35841412 | Neuropathologic scales of cerebrovascular disease associated with diffusion changes on MRI. | Acta Neuropathol | 2022 |
| 35410920 | Author Response: Progressive Auditory Verbal Agnosia Secondary to Alzheimer Disease. | Neurology | 2022 |
| 35543643 | PET Imaging of Dementia: Update 2022. | Clin Nucl Med | 2022 |